IP Library › Assignment 075921/0596

Patent Assignment

Reel/Frame 075921/0596

Security Interest

Recorded: 2026-07-06 Pages: 13

View PDF Order Certified Copy

Assignor

FLAMEL IRELAND LIMITED

Executed: 2026-05-22

Assignee

JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT

10 S. DEARBORN ST., L2, CHICAGO, ILLINOIS, 60603

Covered Properties (66)

Methods of Administering Gamma-Hydroxybutyrate Compositions with Divalproex Sodium

Application: 18/207,728 →

Publication: US US20240024263A1

Gamma-Hydroxybutyrate Formulations Having Improved Stability After Storage

Application: 18/605,502 →

Publication: US US20240216283A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 18/975,536 →

Publication: US US20250099417A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 19/013,473 →

Publication: US US20250152546A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 19/078,638 →

Publication: US US20250205187A1

Methods of Administering Gamma-Hydroxybutyrate Compositions with Divalproex Sodium

Application: 19/307,151 →

Publication: US US20250387361A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 19/347,400 →

Publication: US US20260083696A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,728,110 →

Application: 19/335,896 →

Publication: US US20260014111A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 19/418,323 →

Publication: US US20260097010A1

Streamlining Fulfillment of Prescriptions Subject to Elevated Regulation

Application: 19/361,943 →

Publication: US US20260112471A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 19/352,061 →

Publication: US US20260091013A1

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Application: 19/013,881 →

Publication: US US20250144057A1

Nightly Dose Packet Storage System

Patent: 1,141,397 →

Application: 29/962,848 →

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Application: 19/410,387 →

Publication: US US20260144768A1

Compressed tablets comprising microcapsules with modified release

Patent: 8,507,003 →

Application: 10/507,886 →

Publication: US US20050266078A1

Controlled-Release Floating Pharmaceutical Compositions

Patent: 9,561,179 →

Application: 12/790,201 →

Publication: US US20100310667A1

Controlled-Release Floating Pharmaceutical Compositions

Patent: 10,092,511 →

Application: 15/201,000 →

Publication: US US20160310420A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,896,572 →

Application: 18/231,581 →

Publication: US US20230381131A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,097,175 →

Application: 18/368,403 →

Publication: US US20240108594A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,097,176 →

Application: 18/388,699 →

Publication: US US20240148685A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,109,186 →

Application: 18/531,095 →

Publication: US US20240180861A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,115,142 →

Application: 18/537,318 →

Publication: US US20240180862A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,115,143 →

Application: 18/537,342 →

Publication: US US20240173286A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,115,144 →

Application: 18/539,946 →

Publication: US US20240226051A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,115,145 →

Application: 18/539,960 →

Publication: US US20240180864A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,128,021 →

Application: 18/643,773 →

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,138,239 →

Application: 18/531,056 →

Publication: US US20240165068A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,144,793 →

Application: 18/537,332 →

Publication: US US20240180863A1

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Patent: 12,167,991 →

Application: 18/758,344 →

Publication: US US20240350437A1

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Patent: 12,167,992 →

Application: 18/758,358 →

Publication: US US20240350438A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,186,298 →

Application: 18/758,081 →

Publication: US US20240358666A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,226,388 →

Application: 18/758,699 →

Publication: US US20240374549A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,226,389 →

Application: 18/759,364 →

Publication: US US20240366547A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,239,625 →

Application: 18/889,023 →

Publication: US US20250009704A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,257,223 →

Application: 18/889,070 →

Publication: US US20250025437A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,263,150 →

Application: 18/759,320 →

Publication: US US20240358667A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,263,151 →

Application: 18/889,055 →

Publication: US US20250009705A1

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Patent: 12,303,478 →

Application: 18/898,132 →

Publication: US US20250017882A1

Nightly Dose Packet Storage Set

Patent: 1,102,889 →

Application: 29/939,436 →

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 10,272,062 →

Application: 15/655,924 →

Publication: US US20180021284A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 10,736,866 →

Application: 16/281,235 →

Publication: US US20190183836A1

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Patent: 10,925,844 →

Application: 16/987,510 →

Publication: US US20200360319A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 10,952,986 →

Application: 16/420,321 →

Publication: US US20190274990A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 10,973,795 →

Application: 16/419,616 →

Publication: US US20190269641A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,000,498 →

Application: 16/431,219 →

Publication: US US20190282532A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,052,061 →

Application: 16/419,516 →

Publication: US US20190269640A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,065,224 →

Application: 16/527,633 →

Publication: US US20200197347A1

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Patent: 11,400,065 →

Application: 16/804,966 →

Publication: US US20200276142A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,504,347 →

Application: 17/497,366 →

Methods of Administering Gamma Hydroxybutyrate Formulations After a High-Fat Meal

Patent: 11,583,510 →

Application: 17/666,205 →

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,602,512 →

Application: 17/497,381 →

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,602,513 →

Application: 17/497,393 →

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,766,418 →

Application: 18/075,980 →

Publication: US US20230172892A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,779,557 →

Application: 17/666,201 →

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,826,335 →

Application: 18/096,508 →

Publication: US US20230172893A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,839,597 →

Application: 17/194,780 →

Publication: US US20210186916A1

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 11,986,451 →

Application: 17/530,096 →

Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,186,296 →

Application: 17/178,117 →

Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State

Patent: 12,226,377 →

Application: 17/837,740 →

Publication: US US20220313635A1

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,295,926 →

Application: 17/731,562 →

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,478,604 →

Application: 17/966,538 →

Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics

Patent: 12,551,457 →

Application: 18/141,666 →

Nightly Dose Packet Storage Set

Patent: 1,032,378 →

Application: 29/770,898 →

Nightly Dose Packet Storage System

Patent: 1,051,587 →

Application: 29/827,076 →

Oral Medicinal Product with Modified Release of at Least One Active Principle in Multimicrocapsular Form

Patent: 47,084 →

Application: 15/166,566 →

Nightly Dose Packet Storage Set

Patent: 1,122,750 →

Application: 29/939,446 →

Related Assignments (21)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Jun 23, 2005

From: JORDA, RAFAEL; AUTANT, PIERRE

To: FLAMEL TECHNOLOGIES

Reel/Frame 016716/0623 →

Assignment of Assignor's Interest Aug 10, 2010

From: CASTAN, CATHERINE; CAISSE, PHILIPPE

To: FLAMEL TECHNOLOGIES

Reel/Frame 024815/0355 →

Assignment of Assignor's Interest Jun 8, 2015

From: FLAMEL TECHNOLOGIES

To: FLAMEL IRELAND LIMITED

Reel/Frame 035804/0989 →

Assignment of Assignor's Interest Oct 7, 2016

From: CASTAN, CATHERINE; CAISSE, PHILIPPE

To: FLAMEL TECHNOLOGIES

Reel/Frame 039966/0034 →

Assignment of Assignor's Interest Oct 7, 2016

From: FLAMEL TECHNOLOGIES

To: FLAMEL IRELAND LIMITED

Reel/Frame 039966/0048 →

Assignment of Assignor's Interest Nov 13, 2023

From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS

To: FLAMEL IRELAND LIMITED,

Reel/Frame 065538/0066 →

Assignment of Assignor's Interest Jun 27, 2024

From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS

To: FLAMEL IRELAND LIMITED

Reel/Frame 067858/0944 →

Assignment of Assignor's Interest Aug 8, 2024

From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS

To: FLAMEL IRELAND LIMITED

Reel/Frame 068225/0220 →

Assignment of Assignor's Interest Sep 16, 2024

From: GUILLARD, HERVÉ

To: FLAMEL IRELAND LIMITED

Reel/Frame 068593/0606 →

Assignment of Assignor's Interest Oct 19, 2025

From: GUILLARD, HERVÉ; MÉGRET, CLAIRE; JEAN-DUBUISSON, JEAN-FRANÇOIS; VAUGHN, JASON

To: FLAMEL IRELAND LIMITED

Reel/Frame 073113/0965 →

Assignment of Assignor's Interest Dec 17, 2025

From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS

To: FLAMEL IRELAND LIMITED

Reel/Frame 073247/0587 →

Assignment of Assignor's Interest Dec 17, 2025

From: GRASSOT, JULIEN

To: FLAMEL IRELAND LIMITED

Reel/Frame 073244/0317 →

Assignment of Assignor's Interest Dec 30, 2025

From: GRASSOT, JULIEN

To: FLAMEL IRELAND LIMITED

Reel/Frame 073334/0583 →

Assignment of Assignor's Interest Jan 27, 2026

From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS

To: FLAMEL IRELAND LIMITED

Reel/Frame 073592/0595 →

Assignment of Assignor's Interest Jan 27, 2026

From: DUBOW, JORDAN; GRANGEON, CENDRINE; GUILLARD, HERVÉ; MÉGRET, CLAIRE

To: FLAMEL IRELAND LIMITED

Reel/Frame 073592/0286 →

Assignment of Assignor's Interest Jan 27, 2026

From: DUBOW, JORDAN; MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON,, JEAN-FRANÇOIS

To: FLAMEL IRELAND LIMITED

Reel/Frame 073592/0033 →

Assignment of Assignor's Interest Jan 27, 2026

From: SCHAEFER, WILLIAM J.; REID, JENNY; KRUCHOWSKI, HEATHER

To: FLAMEL IRELAND LIMITED

Reel/Frame 073591/0647 →

Assignment of Assignor's Interest Feb 26, 2026

From: CHUBA, ROBERT; BURROUGHS, DANIELLE SUZANNE; SULLIVAN, MEGGAN CURTA; FENTON, JOSEPH V.

To: FLAMEL IRELAND LIMITED

Reel/Frame 073908/0716 →

Assignment of Assignor's Interest Jun 17, 2026

From: GRASSOT, JULIEN; GRANGEON, CENDRINE; DUBOW, JORDAN; VAUGHN, JASON

To: FLAMEL IRELAND LIMITED

Reel/Frame 074983/0745 →

Assignment of Assignor's Interest Jun 25, 2026

From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS; DUBOW, JORDAN

To: FLAMEL IRELAND LIMITED

Reel/Frame 075077/0587 →

Assignment of Assignor's Interest Jun 25, 2026

From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS; DUBOW, JORDAN

To: FLAMEL IRELAND LIMITED

Reel/Frame 075077/0551 →